论文部分内容阅读
目的探讨厄贝沙坦联合氢氯噻嗪对高血压伴糖尿病患者的疗效观察。方法在门诊筛选120例高血压伴糖尿病患者进行随机分为观察组和对照组各60例。观察组服用厄贝沙坦150mg+氢氯噻嗪12.5mg,口服,每日一次;对照组给予厄贝沙坦150mg,口服,每日一次。结果通过统计分析,观察组显效和有效共55例,总有效率为91.7%;对照组显效和有效共48例,总有效率为80.0%。观察组和对照组总有效率比较有统计学差异(P<0.01)。结论厄贝沙坦联合氢氯噻嗪对高血压伴糖尿病患者的疗效可靠。
Objective To investigate the efficacy of irbesartan combined with hydrochlorothiazide in patients with hypertension and diabetes mellitus. Methods In the outpatient screening of 120 cases of hypertension with diabetes were randomly divided into observation group and control group of 60 cases. The observation group taking irbesartan 150mg + hydrochlorothiazide 12.5mg, orally, once daily; the control group given irbesartan 150mg, orally, once daily. Results By statistical analysis, the observation group was effective and effective a total of 55 cases, the total effective rate was 91.7%; the control group was effective and effective in 48 cases, the total effective rate was 80.0%. The total effective rate in observation group and control group was statistically significant (P <0.01). Conclusion Irbesartan combined with hydrochlorothiazide has a reliable effect on patients with hypertension and diabetes mellitus.